Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.7277
Nov 19 • 3:59 PM ET Dollar change-0.0113 Percentage change(-1.53%)
Aftermarket Close
1.13
Aftermarket • 7:59 PM ET Dollar change+0.40 Percentage change(55.49%)
Nov 19, 4:15 PMDataMEDS agreed to acquire Todos Medical’s TBIA cancer blood-test platform and other assets for Helomics, subject to court approval.
Index
-
Market Cap
4.16M
Enterprise Value
25.68M
Income
-43.37M
Sales
7.68M
Book/sh
-0.36
Cash/sh
0.08
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Feb 21, 2025
P/E
-
Forward P/E
-
PEG
-
P/S
0.54
P/B
-
P/C
8.67
P/FCF
-
EV/EBITDA
-
EV/Sales
3.34
Quick Ratio
0.10
Current Ratio
0.14
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / No
EPS (ttm)
-21.45
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
-2054.20% -
Sales past 3/5Y
- -
EPS Y/Y TTM
62.15%
Sales Y/Y TTM
-77.47%
EPS Q/Q
113.94%
Sales Q/Q
-11.42%
Insider Own
49.63%
Insider Trans
0.00%
Inst Own
1.67%
Inst Trans
15.68%
ROA
-94.78%
ROE
-1706.65%
ROIC
-13693.22%
Gross Margin
-116.47%
Oper. Margin
-384.58%
Profit Margin
-564.77%
SMA20
-46.78%
SMA50
-70.42%
SMA200
-84.22%
Trades
Shs Outstand
4.73M
Shs Float
2.27M
52W High
33.12 -97.80%
52W Low
0.49 47.76%
Volatility
44.30% 22.49%
ATR (14)
0.31
RSI (14)
28.52
Beta
-2.04
Rel Volume
3.46
Avg Volume
6.60M
Volume
22,842,905
Perf Week
-16.38%
Perf Month
-73.25%
Perf Quarter
-46.88%
Perf Half Y
-86.40%
Perf YTD
-96.36%
Perf Year
-97.49%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.74
Price
0.73
Change %
-1.53%
DataMeds AI, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
R.Ph.Mr. Prashant Patel M.Sc.
Interim-CFOMr. Eric Michael Sherb CPA
Interim Co-Chief Executive OfficerMr. Gerald E. Commissiong
Chief Technology OfficerMr. Brett Thompson
Chief Clinical OfficerDr. Shafaat Pirani Pharm.D.